Canada: Canada Bank lowers its rates and risk rates for the economy

Canada: Canada Bank lowers its rates and risk rates for the economy

PROMIT MUKHERJEE and DAVID LJUNGGREN OTTAWA (Reuters) – The Bank of Canada (BOC) decided on Wednesday to lower its main…
NVIDIA: Tech Chinese companies can no longer buy NVIDIA chips whose title fell on the stock market

NVIDIA: Tech Chinese companies can no longer buy NVIDIA chips whose title fell on the stock market

(BFM Stock Exchange) – China has pronounced a ban for the country’s technological companies to buy chips from the American…
Market: General Mills maintains its annual objectives, weakening of demand in North America

Market: General Mills maintains its annual objectives, weakening of demand in North America

General Mills announced on Wednesday to maintain its annual objectives, despite a decline in demand in North America, while sales…
Market: Verisure plans an IPO in Sweden, plans to raise 3.1 billion euros

Market: Verisure plans an IPO in Sweden, plans to raise 3.1 billion euros

by Terje Solsvik and Charlie Conchie OSLO (Reuters) – Verisure security service company, based in Switzerland, announced its intention to…
Market: Wall Street View without direction, Caution Europe before the Fed

Market: Wall Street View without direction, Caution Europe before the Fed

by Diana Mandia (Reuters) – Wall Street is seen without management and the European scholarships evolve on a prudent note…
EUR/USD: the pressure dollar before the plots dowry

EUR/USD: the pressure dollar before the plots dowry

(BFM Stock Exchange) – This article, with free access, is produced by the research team in BFM Stock Exchange analysis…
CAC 40: Pending the Fed’s decision on its rates, the Paris Stock Exchange patina

CAC 40: Pending the Fed’s decision on its rates, the Paris Stock Exchange patina

(BFM Stock Exchange) – The CAC 40 lacks inspiration, pending the decision of the American Federal Reserve (Fed) which should,…
Maat Pharma: Evaluating its financial visibility until the end of February 2026, the specialist in the microbiota Maat Pharma is progressing on the stock market

Maat Pharma: Evaluating its financial visibility until the end of February 2026, the specialist in the microbiota Maat Pharma is progressing on the stock market

(BFM Stock Exchange) – The Lyon Biotech indicated on the occasion of the publication of its half -yearly results having…
Euro zone: revised inflation at 2% over one year in August

Euro zone: revised inflation at 2% over one year in August

(Reuters) – Inflation in the euro zone remained stable in August, in accordance with the target of 2% set by…
Aubay: annoying graphic scenario

Aubay: annoying graphic scenario

(BFM Stock Exchange) – This article, with free access, is produced by the research team in BFM Stock Exchange analysis…